CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30391% above fair value
$6.27+0.00 (0.00%)
Close on Nov 12, 2026Market cap $313.79MP/E –Yield –
CapsoVision enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CapsoVision's enterprise value was $313.70M on Nov 11, 2026, against $261.61M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $313.70M | -37.3% |
| 2025 | Dec 31, 2025 | $500.28M | – |
See a number that looks wrong?